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The cyclin-dependent kinase Cdc28p regulates distinct modes of
Cdc6p proteolysis during the budding yeast cell cycle
Lucy S. Drury, Gordon Perkins* and John F.X. Diffley 
Background: Cdc28p, the major cyclin-dependent kinase in budding yeast,
prevents re-replication within each cell cycle by preventing the reassembly of
Cdc6p-dependent pre-replicative complexes (pre-RCs) once origins have fired.
Cdc6p is a rapidly degraded protein that must be synthesised in each cell cycle
and is present only during the G1 phase.
Results: We found that, at different times in the cell cycle, there are distinct
modes of Cdc6p proteolysis. Before Start, Cdc6p proteolysis did not require
either the anaphase-promoting complex (APC/C) or the SCF complex, which
mediate the major cell cycle regulated ubiquitination pathways, nor did it require
Cdc28p activity or any of the potential Cdc28p phosphorylation sites in Cdc6p.
In fact, the activation of B cyclin (Clb)–Cdc28p kinase inactivated this pathway
of Cdc6p degradation later in the cell cycle. Activation of the G1 cyclins (Clns)
caused Cdc6p degradation to become extremely rapid. This degradation
required the SCFCDC4 and Cdc28p consensus sites in Cdc6p, but did not
require Clb5 and Clb6. Later in the cell cycle, SCFCDC4-dependent Cdc6p
proteolysis remained active but became less rapid.
Conclusions: Levels of Cdc6p are regulated in several ways by the Cdc28p
cyclin-dependent kinase. The Cln-dependent elimination of Cdc6p, which does
not require the S-phase-promoting cyclins Clb5 and Clb6, suggests that the
ability to assemble pre-RCs is lost before, not concomitant with, origin firing.
Background
In eukaryotic cells, DNA replication initiates from large
numbers of replication origins on multiple chromosomes
throughout S phase of the cell cycle. Mechanisms ensur-
ing that replication origins fire just once in each cell cycle
have been intensively investigated in recent years [1,2].
One of the keys to preventing reinitiation of DNA replica-
tion involves the regulated assembly of pre-replicative
complexes (pre-RCs) at replication origins [3–5]. During
pre-RC assembly, the Mcm2–7 family of proteins are
loaded onto DNA in a reaction that requires the origin-
recognition complex (ORC) and Cdc6p [6–12].
Once an origin fires, the pre-RC is lost from the origin and
does not reassemble until the end of the following mitosis [3].
Pre-RCs normally assemble during G1 phase and cannot
assemble later in the cell cycle because the major cyclin-
dependent kinase (Cdk) Cdc28p, together with B cyclin
(Clb), prevents pre-RC formation [4,5,13,14]. As
Clb–Cdc28p kinase is also essential for initiating DNA
replication [15], pre-RC assembly and origin firing are
mutually exclusive events. Pre-RC assembly is prevented
from the onset of S phase until the end of mitosis.
Cdc6p appears to be a key player in preventing re-replica-
tion. Overexpression of Cdc18, the fission yeast Cdc6p
homologue, drives multiple rounds of DNA re-replication
without mitosis [16–22]. Moreover, a budding yeast cdc6
mutation that causes limited re-replication has been
described [7]. In both budding and fission yeast, Cdc6p
(and cdc18) are unstable proteins that must be synthesised
in each cell cycle for DNA replication [16,23]. These pro-
teins are present during G1 and disappear around the time
of S-phase entry. In human cells, Cdc6p appears to be
present throughout most of the cell cycle in proliferating
cells but is lost when cells enter quiescence [24–26]. In
budding yeast, Cdk phosphorylation of Cdc6p is required
for ubiquitination in vitro, and mutation of Cdk consensus
phosphorylation sites in Cdc6p stabilises it [27], suggest-
ing a role for Cdks in Cdc6p degradation in vivo.
In both budding and fission yeast, the SCF complex plays
a role in Cdc6p (cdc18) degradation [5,28,29]. In budding
yeast, SCF is a multisubunit protein complex required to
target a number of key cell-cycle regulators for ubiquitin-
mediated degradation [30]. SCF contains Skp1, the E2
ubiquitin ligase Cdc34 and the cullin Cdc53 along with
one of a number of F-box-containing proteins. In the case
of Cdc6p degradation, the F-box protein Cdc4p appears to
be the most important component [5,29]; cdc4 mutants,
along with cdc34 and cdc53 mutants, are unable to degrade
Cdc6p in cells arrested in mitosis. Cdc4 interacts with
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multiple elements in the amino-terminal 47 amino acids of
Cdc6p. This amino-terminal domain is not essential for
the biochemical activity of Cdc6p in loading of minichro-
mosome-maintenance proteins (Mcms) but is required for
Cdc6p degradation throughout the cell cycle [29]. 
Here, we have examined the role of Cdc28p in the degra-
dation of Cdc6p in vivo. Cdc6p degradation was found to
be surprisingly complex. Before the activation of Cdc28p
at Start, Cdc6p was targeted for degradation by a pathway
that did not involve SCF. This SCF-independent pathway
was inactivated by Clb–Cdc28p later in the cell cycle.
Late in G1, Cdc28p caused the rapid degradation of
Cdc6p by SCF. The rapid degradation of Cdc6p was
driven by the G1 cyclin (Cln) form of Cdc28p. Later in the
cell cycle, Clb–Cdc28p also drove SCF-dependent degra-
dation of Cdc6p, although at a slower rate. 
Results
Cdc6p proteolysis before Start does not require SCF
We showed previously, using the yeast two-hybrid system,
that Cdc6p interacts with Cdc4p, a component of SCF [29].
Moreover, the degradation of Cdc6p in nocodazole-
arrested cells completely depends on the SCF compo-
nents Cdcs 4, 34 and 53, and requires the amino-terminal
47 amino acids of Cdc6p which interact with Cdc4p
in vivo. Surprisingly, however, Cdc6p is equally unstable
in cells arrested with either α factor or nocodazole. This
contrasts sharply with one of the best-characterised SCF
substrates, Sic1p, which is stable in α-factor-arrested cells
but is highly unstable in nocodazole-arrested cells [15].
We set out to investigate this paradox by examining the
genetic requirements for Cdc6p degradation in α-factor-
arrested cells. First, we examined the role of SCF in this
degradation. In the experiment shown in Figure 1a,
wild-type or SCF temperature-sensitive mutant cells
(cdc4, cdc34, cdc53) containing an additional copy of the
wild-type CDC6 gene under the control of the GAL1,10
promoter were first arrested with α factor in raffinose-con-
taining medium at the permissive temperature (24°C).
Cdc6p was then expressed and SCF was inactivated by
transferring the cells to galactose-containing medium at
the restrictive temperature (37°C) for 30 minutes. New
Cdc6p synthesis was then blocked by addition of glucose to
the medium (to repress transcription) and cycloheximide
(to prevent translation of any remaining CDC6 mRNA).
Samples were taken at the indicated times and Cdc6p
levels were determined by immunoblotting with a mono-
clonal antibody to Cdc6p. Figure 1a shows that, in α-factor-
arrested cells, Cdc6p was rapidly degraded, not only in
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Figure 1
Cdc6p degradation in G1 is not dependent on SCF, APC, active Clns
or consensus phosphorylation sites. (a) Wild-type (WT, lanes 1–4),
cdc4 (lanes 5–8), cdc34 (lanes 9–12) and cdc53 (lanes 13–16) cells
containing GAL1,10–CDC6 were grown at 24°C in YP medium
containing raffinose (YP-Raf) and blocked in G1 with α factor. The
cultures were transferred to medium containing galactose at 37°C to
induce Cdc6p. After 30 min, Cdc6p expression was repressed.
Samples were taken at the time of repression and after, at the
indicated times, to be processed for immunoblotting with a monoclonal
raised against Cdc6p. LC, loading control (a section of the membrane
between the 66 kDa and 45 kDa markers, stained with amido black
after ECL detection of the proteins). (b) (i) A similar experiment was
performed on temperature-sensitive cdc16 (lanes 1–4) and cdc23
(lanes 5–8) cells. (ii) The stability of Cdc6p and of a fusion protein
between Clb2p and Myc (Clb2p–Myc), both expressed from the
GAL1,10 promoter, was examined in a wild-type or a cdc16 mutant
background as described above. The band below Clb2p–Myc
(asterisk) is a non-specific band also seen in extracts from untagged
strains (data not shown). (c) Logarithmically growing YLD38 cells
(CLN1-3∆, MET–CLN2) were blocked in G1 by the addition of
methionine to the medium. Cdc6p expression was induced and
repressed as described above and samples were taken at the times
indicated and processed for immunoblotting. (d) FACS analysis of a
strain (YLD53) expressing GAL1,10–CDC6-S/TP(1–8)Ap as the only
copy of CDC6, compared with a congenic strain expressing only
GAL–CDC6 (YLD52). DNA content is indicated as haploid (1C) or
diploid (2C). (e,f) Cdc6-S/TP(1–8)Ap is unstable after transcriptional
and translational repression in (e) α-factor-blocked cells (YLD35) but is
(f) stabilised in the same cells blocked in nocodazole (NOC). In
(a,b,c,e,f) the arrow indicates Cdc6p.
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wild-type cells (lanes 1–4), but also in cdc4, cdc34 and cdc53
mutants at the restrictive temperature (lanes 5–16). Under
otherwise identical conditions in the same strains, Cdc6p
became highly stabilised in the SCF mutants in nocoda-
zole-arrested cells. Therefore, Cdc6p degradation during
pre-Start G1, in contrast to mitosis, does not require SCF.
The anaphase-promoting complex, also known as the cyclo-
some (APC/C), mediates the second major pathway for the
regulated proteolysis of key cell-cycle constituents. The
APC/C is responsible for targeting a number of proteins
including the B cyclins for ubiquitin-mediated degrada-
tion [30]. As the APC/C remains active in α-factor-arrested
cells [31], we considered the possibility that it might be
required for the pre-Start degradation of Cdc6p. Figure 1b(i)
shows an experiment essentially identical to that in
Figure 1a except that two APC/C mutants, cdc16 and cdc23,
were tested. Cdc6p remained as unstable in these APC/C
mutants as it was in wild-type cells. These strains have pre-
viously been shown to be defective in degradation of the
APC/C substrate Dbf4p [32]. To ensure that the APC/C is
inactive, we constructed wild-type and cdc16 mutant strains
in which both Cdc6p and Clb2p were expressed from the
GAL1,10 promoter. Figure 1b(ii) shows that, in wild-type
cells arrested in α factor, both Cdc6p and Clb2p were highly
unstable. In the cdc16 mutant, Cdc6p was equally unstable,
but Clb2 was significantly stabilised. From these experi-
ments, we conclude that neither the APC/C nor SCF is
required for Cdc6p proteolysis during pre-Start G1.
The proteolysis of Cdc6p seen in α-factor-arrested cells
might be a response to mating pheromone that is unrelated
to the cell cycle. Alternatively, this degradation may be
due to the mating-pheromone-induced inhibition of G1
Cln activity. To test this, we examined Cdc6p degradation
in cells that have been arrested in pre-Start G1 by G1 Cln
depletion. Cells in which two CLN genes (CLN1 and
CLN3) were deleted and the third (CLN2) placed under the
repressible MET3 promoter were arrested in G1 by addi-
tion of methionine to the medium. After arrest, Cdc6p was
induced for 30 minutes and repressed as above. As in α-
factor-arrested cells, Cdc6p was unstable in Cln-depleted
cells (Figure 1c). Therefore, Cln–Cdc28p kinase is not
required for degradation of Cdc6p in these pre-Start
arrested cells.
The Cdc6p protein contains eight SP or TP motifs that
might act in vivo as sites for phosphorylation by Cdks. As
an alternative approach to examine the role of Cdc28p in
Cdc6p degradation, we constructed a CDC6 gene in
which the phospho-accepting amino-acid residue (S or T,
in the single-letter amino-acid code) in all eight sites was
mutated to A (Cdc6-S/TP(1–8)A). When we replaced the
endogenous CDC6 gene with this mutant by plasmid
shuffle, we found that, when this was the only copy of
Cdc6p, cells were viable, had apparently normal cell-
cycle kinetics and showed no evidence of re-replication,
as determined by flow cytometry, indicating that this
mutant Cdc6p protein is functional for regulated DNA
replication (Figure 1d). Both wild-type Cdc6p and
Cdc6-S/TP(1–8)A were degraded at the same rate in
α-factor-arrested cells (Figure 1e). Therefore, neither
Cdc28p nor any of the potential Cdk consensus sites in
Cdc6p are required for degradation of Cdc6p before
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Figure 2
SCFCDC4 is required for the rapid degradation
of Cdc6p in late G1. (a) YCD4 (cdc4-1,
SIC1∆, GAL–CDC6) cells were blocked in
G1 with α factor in YP-Raf at 24°C. The cells
were then transferred to YP medium
containing raffinose and galactose
(YP-Raf,Gal) and α factor at 37°C. After
30 min, the cells were released into the cell
cycle in YP-Raf,Gal at 37°C. Samples were
taken at the indicated times for FACS analysis
(bottom panels) and to determine the budding
index (upper panels). Samples were also
taken and processed for immunoblotting to
detect Cdc6p (middle panels). LC, loading
control (see legend to Figure 1). Lanes 1–10
correspond to the times at which the samples
were taken, in 10 min intervals from 0 to 90
min. (b) A second, similar, experiment using
YCD3 cells (cdc4-1, SIC1∆) was performed.
In this case, Cdc6p was expressed from its
own promoter and the cells were kept in YP-
Raf for the duration of the experiment. 
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Start. We designate this pre-Start degradation of Cdc6p as
‘mode 1’, which is independent of SCF and Cln–Cdc28p.
This contrasts with the SCF-dependent degradation of
Cdc6p in nocodazole-arrested cells. Although the wild-
type Cdc6p is rapidly degraded [29], Cdc6-S/TP(1–8)A was
stabilised in these nocodazole-arrested cells (Figure 1f).
Therefore, one or more of the potential Cdc28p phosphoryl-
ation sites is important for the degradation of Cdc6p
during mitosis.
Degradation of Cdc6p in late G1 phase requires SCF
Although Cdc6p was degraded moderately rapidly in cells
arrested in either α factor or nocodazole, we have previ-
ously shown several lines of evidence that Cdc6p is much
more rapidly degraded during late G1/early S phase [29].
First, when Cdc6p is constitutively expressed from the
GAL1,10 promoter, it disappears soon after release from α
factor and does not appear again until later in the cell cycle,
showing that Cdc6p cannot accumulate to high levels
during S phase even when it is transcribed at high levels.
Second, Cdc6p is so unstable in cdc7-arrested cells (late
G1) that we have not been able to determine a half life.
Finally, in hydroxyurea-arrested cells (early S phase), we
are unable to detect Cdc6p even when expressed from the
strong GAL1,10 promoter. In the absence of SCFCDC4 func-
tion, however, Cdc6p is present at high levels and is stable
in hydroxyurea-arrested cells. Together, these experiments
indicate that Cdc6p is very rapidly degraded during late
G1/early S phase by the SCF pathway. To examine the
role of SCF in this late G1/early S phase degradation of
Cdc6p in unblocked cells, we exploited the fact that Cdc4p
is not essential for S-phase entry in cells in which SIC1 has
been deleted [15]. We arrested a culture of a cdc4, SIC1∆
double mutant at 24°C and released the cells at 37°C to
inactivate Cdc4p. In the absence of SCFCDC4 activity, the
rapid degradation of Cdc6p in late G1 did not occur and
Cdc6p continued to accumulate during the remainder of
the cell cycle (Figure 2a). The lower levels of Cdc6p at the
beginning of the experiment are likely to be due to the fact
that mode 1 degradation is active in the α-factor-arrested
cells and that induction of the GAL1,10 promoter is less
efficient at 37°C. Even when Cdc6p was expressed from
its own promoter, it was not degraded before S-phase entry
(Figure 2b) as it is in wild-type cells ([29] and see below).
Taken with results previously published, this shows that
the post-Start degradation of Cdc6p during late G1/early S
phase is dependent on SCFCDC4. We designate this rapid,
SCF-dependent degradation of Cdc6p in late G1 as
‘mode 2’ and the less rapid SCF-dependent degradation
seen in nocodazole-arrested cells as ‘mode 3’. 
Mode 2 proteolysis requires Cln but not Clb5,6 activity
As this rapid Cdc6p destruction occurred after α-factor-
release and is, therefore, downstream of Start, we were
interested in testing the requirement for Cdc28p. To
begin to examine this, we arrested a population of cells
expressing Cdc6p from the GAL1,10 promoter in pre-Start
G1 by Cln depletion as above (Figure 1c). Cdc6p could be
readily detected in these arrested cells (Figure 3, lane 1),
consistent with the experiment in Figure 1c. The culture
was then released from the G1 arrest by transferring to
methionine-free medium to induce Cln expression. This
medium also contained galactose to ensure continued
Cdc6p expression. After release and concomitant with
budding, Cdc6p disappeared and reappeared later in the
cell cycle (Figure 3, lanes 1–9). Therefore, activation of
Cln2–Cdc28p is sufficient to activate the rapid degrada-
tion of Cdc6p in late G1/early S phase.
SCF substrates, such as Sic1p, must be phosphorylated in
order to be recognised for polyubiquitination. Therefore,
we determined whether the potential Cdk phosphorylation
sites on Cdc6p were required for the rapid, SCF-dependent
degradation of Cdc6p downstream of Start. Cells containing
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Figure 3
Cdc6p degradation in late G1 requires Cln activity. A logarithmically
growing culture of YLD38 cells (CLN1-3∆, MET–CLN2, GAL–CDC6)
was arrested in G1 by the addition of methionine. Cdc6p (arrow) was
induced for 45 min, following which the cells were released into the
cell cycle in methionine-free medium containing galactose. Samples
(lanes 1–10) were taken at the indicated times to determine the
budding index (upper panel), for FACS analysis (bottom panel) and to
be processed for immunoblotting (middle panel).
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GAL–Cdc6-S/TP(1–8)A were arrested in α factor and released
into galactose-containing medium. Figure 4 shows that,
although the Sic1 protein was rapidly degraded as buds
emerged in cells expressing either wild-type Cdc6p or
Cdc6-S/TP(1–8)Ap, Cdc6-S/TP(1–8)Ap was not rapidly
degraded as cells entered S phase. Thus, at least a subset of
Cdk sites is required for the rapid degradation of Cdc6p.
Clns drive S phase by promoting the accumulation of
B cyclin (Clb)–Cdc28p. This is accomplished in three
ways: by targeting the Clb–Cdc28p inhibitor Sic1p for
degradation by the SCFCDC4 pathway; by inactivating the
APC/C, thus stabilising the B cyclins; and by inducing
transcription of the first set of Clbs, Clb5 and Clb6. Thus,
Clns might trigger rapid Cdc6p degradation either directly
or indirectly, by activating Clb5 and Clb6, which in turn
might phosphorylate Cdc6p, targeting it for degradation.
These two possibilities can be distinguished because Clb5
and Clb6, which normally trigger the initiation of DNA
replication, are non-essential. In their absence, other Clbs
can support DNA replication. Nevertheless, because there
is a delay before other Clbs are activated, the onset of
DNA replication is significantly delayed in strains lacking
Clb5 and Clb6 (clb5,6∆). If rapid Cdc6p degradation is trig-
gered by Clbs, then, in the absence of Clb5 and Clb6, rapid
degradation should either be alleviated or delayed until the
other Clbs are expressed. Alternatively, if Clns directly
target Cdc6p for degradation, rapid degradation should not
be delayed in the clb5,6∆ strain. In Figure 5a, cells express-
ing wild-type Cdc6p from the GAL1,10 promoter in either
a wild-type or a clb5,6∆ mutant background were arrested
in G1 with α factor and released. Flow cytometry showed
that, as expected, entry into S phase was delayed by
approximately 45 minutes in the clb5,6∆ mutant whereas
budding (a Cln-, not Clb-, dependent process) occurred at
approximately the same time in the two strains.
Immunoblot analysis showed that rapid Cdc6p degrada-
tion, like budding, occurred at the same time in the two
strains. Moreover, Cdc6p degradation occurred at the same
time as Cln-dependent Sic1p degradation. Taken together
with the experiment shown in Figure 3, these results
demonstrate that the rapid degradation of Cdc6p at the
end of G1 phase is dependent on Clns but is not depen-
dent on Clb5 and Clb6. 
The experiments described above used Cdc6p expressed
from the GAL1,10 promoter. We were interested in deter-
mining whether the degradation of Cdc6p expressed from
its own promoter was also independent of Clb5 and Clb6
activation. After cells are released from α factor arrest,
there is a burst of CDC6 transcription [23,33–35] and syn-
thesis [23,29] before entry into S phase. Therefore, we
examined Cdc6p levels after release from an α factor
arrest in either wild-type cells or a clb5,6∆ mutant contain-
ing just the endogenous CDC6 gene. Figure 5b shows that
both the appearance and disappearance of Cdc6p soon
after release from α factor occurred at the same time in the
wild type and in clb5,6∆ mutants. There was a delay in
Cdc6p appearance in the next cell cycle in the clb5,6∆
mutant. This was presumably due to a delay in entering
mitosis, in response to the delay in S-phase completion.
This shows that the degradation of Cdc6p expressed from
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Figure 4
The SP/TP motifs are required for rapid
degradation of Cdc6p in late G1.
Asynchronous cultures of YLD16
(GAL–CDC6) and YLD35 (GAL–CDC6-
S/TP(1–8)A) cells were synchronised with
α factor in YP-Raf. Galactose was added to
induce Cdc6p or Cdc6-S/TP(1–8)Ap (upper
arrows); 30 min later, the cells were released
into the cell cycle in YP-Raf,Gal. Samples
were taken at the indicated times to determine
the budding index (lower left panel), for FACS
analysis (lower right panels) and to be
processed for immunoblotting to detect
Cdc6p, Cdc6-S/TP(1–8)Ap and Sic1p (upper
panels). Lanes 1–9 correspond to the times at
which the samples were taken, in 10 min
intervals from 0 to 80 min.
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its own promoter occurs downstream of Start but does not
require activation by Clb5 and Clb6. Taken together,
these experiments show that mode 2 activation requires
Cln–Cdc28 but does not require Clb5 and Clb6.
Pre-Start degradation of Cdc6p is inhibited by Cdc28p
In nocodazole-arrested cells, Cdc6p degradation was
entirely dependent on SCFCDC4. Thus, mode 1 appears to
be unable to degrade Cdc6p later in the cell cycle. We were,
therefore, interested in testing the possibility that mode 1 is
inhibited by Cdc28p. To begin to address this, we exploited
the fact that mode 1 was capable of rapidly degrading Cdc6-
S/TP(1–8)Ap while modes 2 and 3 were not. Figure 6a shows
that Cdc6-S/TP(1–8)Ap was rapidly degraded in cdc4 cells
arrested at the restrictive temperature. As cdc4 mutants
arrest with high levels of Cln–Cdc28p kinase, low levels of
Clb–Cdc28p kinase and inactive SCFCDC4, we conclude
that mode 1 is still active after Cln–Cdc28p kinase activa-
tion but before Clb–Cdc28p kinase activation.
We next tested whether inactivation of Cdc28p later in
the cell cycle could activate mode 1. We arrested cells in
nocodazole then inactivated all forms of Cdc28p using the
temperature-sensitive cdc28 degron mutant [36,37]. This
treatment is sufficient to promote re-entry of Mcm4 into
the nucleus [36] and to promote the assembly of pre-RCs
at origins [13]. Figure 6b shows that, after Cdc28p inacti-
vation in nocodazole-arrested cells, both wild type and
Cdc6-S/TP(1–8)Ap were degraded at the same rate. There-
fore, inactivation of Cdc28p promotes reactivation of
mode 1 degradation in mitosis.
Finally, we determined whether activation of Clb kinase is
sufficient to inactivate mode 1 degradation during G1. Cells
were arrested in α factor and Clb2∆1-102 was expressed.
Clb2∆1-102 is a form of Clb2 in which the destruction box,
required for APC/C-mediated degradation, has been
removed. Expression of Clb2∆1-102 can induce S phase in
α-factor-arrested cells but does not induce budding, a Cln-
dependent phenomenon. Figure 6c shows that, after
Clb2∆1-102 expression, Cdc6-S/TP(1–8)Ap became sta-
bilised relative to wild-type Cdc6p. Therefore, Clb expres-
sion is sufficient to inactivate mode 1 during G1.
Mode 1 cannot degrade Cdc6p made in the previous
cell cycle
The finding that Cdc6p degradation before Start does not
require SCF does not appear consistent with the results
of an experiment we previously published showing that
cdc4 mutant cells are defective in degrading Cdc6p if
released from a nocodazole block into an α-factor block at
the restrictive temperature [29]. In this experiment,
Cdc6p, expressed from its own promoter, first appears in
both mutant and wild-type cells late in mitosis. Most of
the Cdc6p in wild-type cells is degraded soon afterwards.
In cdc4 mutant cells however, Cdc6p levels do not signifi-
cantly decline. One possible explanation for this is that
Cdc6p, which is synthesised before exit from mitosis, is
normally degraded by SCFCDC4 and cannot be degraded
by the mode 1 pathway. To test this, wild-type and cdc4
mutant cells containing GAL–CDC6 were first arrested in
mitosis with nocodazole in raffinose-containing medium,
transferred to 37°C for 15 minutes and galactose was then
added for a further 15 minutes to induce Cdc6p. The
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Figure 5
Clb5 and Clb6 are not required for degradation of Cdc6p in late G1.
(a) Wild-type (WT; CLB5,6+, GAL–CDC6) and YKL125 (clb5,6∆,
GAL–CDC6) cells were grown in YP medium containing galactose
(YP-Gal) and arrested in G1 with α factor. They were then released
into the cell cycle in YP-Gal. Samples were taken at the indicated
times for FACS analysis (left) and to be processed for immunoblotting
(right). (b) A similar experiment as in (a) was performed with wild-type
(CLB5,6+) and YKL124 (clb5,6∆) cells. After release from an α factor
block in YPD, samples were taken at the times indicated for FACS
(bottom panels), to determine the budding index (upper panel) and to
be processed for immunoblotting (middle panels). Lanes 1–10 and
11–20 correspond to the times at which the samples were taken, in
10 min intervals from 0 to 90 min.
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cells were then transferred to 37°C in medium lacking
nocodazole but containing glucose and α factor. Thus, a
pulse of Cdc6p was made in mitosis and its fate followed as
cells exited mitosis and entered G1. Figure 7a shows that,
while Cdc6p rapidly disappeared from wild-type cells, it
persisted in the cdc4 mutant cells for a long period of time. 
Although this suggests that mode 1 degradation cannot
operate on Cdc6p made in the previous cell cycle, it is also
possible that Cdc4p is required at some point between the
nocodazole-and α factor arrest to activate mode 1. To test
this, wild-type and cdc4 mutant cells were released from
the nocodazole block into α factor at 37°C as in Figure 7a
except that CDC6 transcription was transiently induced
after cells had passed through mitosis. Figure 7b shows
that, in contrast to Figure 7a, Cdc6p synthesised after cells
had passed through mitosis was rapidly degraded in the
cdc4 mutant. This result is most consistent with the idea
that Cdc6p made before exit from mitosis must be
degraded by SCFCDC4 and cannot be degraded by the
SCFCDC4-independent pre-Start mode of degradation.
Discussion
In this paper, we have defined three modes of Cdc6p prote-
olysis that can be distinguished on the basis of rates and cis-
and trans-acting mutations. These are summarised in
Figure 8. Before Start, we found that Cdc6p was degraded
through mode 1. Mode 1 degradation was moderately rapid
and characterised by two major features. First, it was inde-
pendent of SCF and APC/C and, second, it did not require
any of the potential Cdc28p phosphorylation sites in Cdc6p.
We do not know how mode 1 degradation works but,
Cdc6∆NTp, a mutant in which the amino-terminal
47 amino acids of Cdc6p are deleted, was stable in G1-
arrested cells, arguing that signals required for mode 1
degradation reside in the amino terminus. Although the
experiments used to define mode 1 degradation presented
here involved expression of Cdc6p from the GAL 1,10 pro-
moter, our previous experiments showed that Cdc6p
expressed from its own promoter is synthesised and then
degraded during pre-Start G1 in wild-type cells ([29];
Figure 3a), showing that Cdc6p proteolysis is active during
pre-Start G1. Mode 2 degradation was extremely rapid and
characterised by the fact that it required SCFCDC4 and at
least some of the potential Cdc28p phosphorylation sites in
Cdc6p. It is likely that this mode of degradation requires
multiple phosphorylation sites as neither Cdc6-S/TP(1–4)Ap
nor Cdc6-S/TP(5–8)Ap was completely stable during S phase
(data not shown). Finally, later in the cell cycle, Cdc6p
degradation slowed down. This degradation remained
dependent on SCFCDC4 and Cdc28p phosphorylation sites.
Modes 2 and 3 differed not only in rate but also in the form
of Cdc28p kinase required for their activation (see below).
Each mode of Cdc6p degradation was regulated by Cdc28p.
Several lines of evidence suggest that SCF-independent
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Figure 6
Clb–Cdc28 kinase inactivates mode 1 of
Cdc6p degradation. (a) cdc4-1 cells were
grown in YP-Raf at 24°C, blocked in G1 with α
factor and then transferred to 37°C in
YP-Raf,Gal for 30 min. The cells were
subsequently released into the cell cycle in
YP-Raf,Gal at 37°C, causing them to block at
the cdc4-1 restriction point; 2 h after release
from α factor, CDC6 expression was
repressed. Samples were taken and processed
for immunoblotting. The arrow indicates Cdc6p.
(b) Cells containing GAL–Ubr1/Cdc28-td
(YLD44 and YLD46) or GAL–Ubr1 alone
(YLD47 and YLD49) as a control were grown
in YP-Raf at 24°C and subsequently blocked in
G2 with nocodazole. Both Ubr1 and either
Cdc6p or Cdc6-S/TP(1–8)Ap were induced by
the addition of galactose. After 30 min, the
cultures were shifted to 37°C to inactivate
Cdc28p. After a further 30 min, Cdc6p or
Cdc6-S/TP(1–8)Ap expression was repressed.
Samples were taken at the time of
transcriptional repression and at the
subsequent times indicated and processed for
immunoblotting. Lane numbers correspond to
the times at the top of the immunoblot; arrows
indicate Cdc6p. (c) Strains containing
GAL–CLB2∆1-102 and either GAL–CDC6
(YLD50) or GAL–CDC6-S/TP(1–8)A (YLD51)
were grown in YP-Raf and blocked with α
factor. Both Clb2∆1-102p (lower arrows) and
Cdc6p or Cdc6-S/TP(1–8)Ap (upper arrows)
were induced by the addition of galactose.
After 30 min, expression of Cdc6p and
Cdc6-S/TP(1–8)Ap was repressed. Samples
were taken and processed for immunoblotting
(upper panels) and FACS analysis (lower
panels). Lane numbers correspond to the times
at the top of the immunoblot.
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mode 1 degradation is inhibited by Cdc28p. First, wild-type
Cdc6p was almost completely stable in nocodazole-arrested
cells in which SCF had been inactivated. Second, Cdc6-
S/TP(1–8)Ap, which could be degraded by mode 1, was
considerably more stable in G2 than in G1. Third, expres-
sion of Clb2∆1-102 in α-factor-arrested cells caused the
stabilisation of Cdc6-S/TP(1–8)Ap. Finally, inactivation of
Cdc28p in mitosis-arrested cells caused Cdc6-S/TP(1–8)Ap
to become unstable. The inhibition of mode 1 by Cdc28p
appeared to be Clb specific as it was still active in cdc4-
arrested cells. We suggest that mode 1 becomes activated
when Clb–Cdc28p kinase is inactivated at the end of
mitosis. Mode 1 is then inactivated by one or more of the
Clb–Cdc28p kinases later in the cell cycle.  At present we
do not know how Clb–Cdc28p inhibits mode 1 degrada-
tion. The fact that Cdc6-S/TP(1–8)Ap, which presumably
cannot be phosphorylated by Cdc28p, is stable in mitosis
suggests that Cdc28p may be acting by inhibiting the
degradation machinery itself rather than through Cdc6p.
Nevertheless, the fact that wild-type Cdc6p made in the
previous cell cycle cannot be degraded during pre-Start G1
suggests that Cdc28p acts directly on Cdc6p. It is possible
that Cdc28p inhibits mode 1 both by inhibiting the degra-
dation machinery and by modifying the substrate at a non-
consensus phosphorylation site. It is interesting to note
that, although human Cdc6 levels do not fluctuate dramati-
cally during the cell cycle, Cdc6p is degraded upon entry
into quiescence [24–26]. Perhaps this degradation occurs
by a pathway related to mode 1.
The rapid SCF-dependent mode 2 degradation of Cdc6p
was activated by Cln–Cdc28p kinase in late G1. As activation
of mode 2 degradation did not require Clb5 and Clb6 and
was not delayed in clb5,6 mutants, and as Cdc6-S/TP(1–8)Ap
was resistant to mode 2 degradation, we suggest that
Cln–Cdc28p kinase acts directly on Cdc6p. Recent bio-
chemical analysis has suggested that Clb5–Cdc28p kinase
is more efficient than Cln2–Cdc28p kinase in promoting
SCFCDC4-dependent polyubiquitination in vitro [27].
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Figure 7
CDC4 is required for the degradation of Cdc6p made in G2 but not
for the Cdc6p made in G1. (a) A pulse of Cdc6p was given in
mitosis to wild-type (WT, YLD15) and cdc4 (YLD16) cells (see text).
The cells were subsequently released into G1 at 37°C without
further Cdc6p expression. Samples were taken at the indicated times
to measure the budding index (upper panel) and to be processed for
immunoblotting (middle and lower panel). Lanes 1–9 and 10–18
correspond to the times at which the samples were taken, in 10 min
intervals from 0 to 80 min. (b) This experiment was performed in a
manner similar to that in (a) except that Cdc6 was induced for
30 min in G1 (α-factor block) at 37°C and then repressed rather
than in mitosis. Samples were taken at the time of repression and at
the indicated times to be processed for immunoblotting.
Figure 8
Three modes of Cdc6 degradation during the cell cycle. The model is
described in the text. The different forms of degradation are
distinguished on the basis of different cis- and trans-acting factors.
The fading of the boxes indicates ambiguities about which factors
inactivate modes 1 and 2 and activate mode 3.
bb10e30.qxd  03/13/2000  01:53  Page 238
Our results in vivo clearly demonstrate that Clb5 and Clb6
are completely dispensable for timely degradation of
Cdc6p before S-phase entry. The reason for the discrep-
ancy is not clear but it is possible that some modification
of Cdc6p in addition to Cln–Cdc28p phosphorylation, or
some additional factor missing from the in vitro reactions,
is required for full activity of mode 2.
CDC6 is transcribed at the end of mitosis in rapidly
growing cells; there is, however, also a burst of CDC6
transcription and synthesis after cells are released from a
G1 arrest [23,33–35] (see Figure 8). Interestingly,
although CDC6 transcription occurs downstream of Start in
such conditions, it occurs well before the transcription of
CLN1 and CLN2. Our results suggest that this may be
important to allow time for Cdc6p to act in Mcm loading
before full Cln activation and rapid Cdc6p degradation.
As Cln activation must occur before Clb activation, our
results suggest that a cell’s capacity to form pre-RCs is
diminished — in this case by Cdc6p degradation — before,
not concomitant with, S-phase entry. The nuclear localisa-
tion of Mcm proteins is regulated in a similar manner [36].
Mcm4 becomes excluded from the nucleus as it is displaced
from chromatin during S phase. Mcm4 which is not chro-
matin bound is, however, exported much earlier, at the end
of G1 phase. This exclusion of the free Mcm proteins
requires active Cln–Cdc28p kinase but, like mode 2 degra-
dation, is not delayed in the clb5,6 mutant. Together, these
results suggest that Cln–Cdc28p acts through several inde-
pendent pathways to downregulate pre-RC assembly, inde-
pendent of its ability to promote S phase via Clb activation.
Many details of Cdc6p proteolysis are unresolved. What
factors are involved in mode 1 degradation? Do the
different modes of degradation target different pools of
Cdc6p (for example, chromatin-bound versus free Cdc6p,
nuclear versus cytoplasmic, etc.)? What is the functional
significance of degrading different pools of Cdc6p? The
results presented here provide a framework for under-
standing the proteolysis of this key cell-cycle regulator. 
Materials and methods
Strains and media
The strains (see Supplementary material) were all derived from W303-1a.
Cell cycle blocks with nocodazole or α factor were as previously
described [3]. FACS analysis was as previously described [38]. The
strains YLD52 and YLD53 contain a single copy of CDC6 or
CDC6-S/TP(1–8)A (for a description of this allele, see below) under the
control of the GAL1,10 promoter and were made by plasmid shuffle [39]
in a strain in which the endogenous CDC6 gene was deleted.
Plasmid constructs
The plasmids containing GAL1,10–CDC6 have been described previ-
ously [29]. To make the GAL1,10–CDC6-S/TP(1–8)A allele, site-
directed mutagenesis was performed using a QuikChange
site-directed mutagenesis kit (Stratagene).The starting template was
GAL1,10–CDC6 in pRS303 [40] and sites were mutated sequentially
with the oligonucleotide primers listed in the Supplementary material. The
final product was sequenced to ensure that only the directed mutations
were present. The fragment containing GAL1,10–CDC6-S/TP(1–8)A
was subsequently subcloned using flanking NotI and SalI restriction sites
in the polylinker into the same acceptor sites in pRS303 (pLD14) and
pRS306 (pLD15). The construct expressing GAL1,10–CLB2–Myc will
be described elsewhere (K. Bousset, personal communication). The
construct expressing GAL1,10–CLB2∆1-102 (pKB19) was made by
subcloning a fragment containing GAL1,10–CLB2∆1-102 from
pKL145 [36] into pRS304. 
GAL1,10 promoter induction, repression and protein
stability experiments.
For induction of the GAL1,10 promoter, cells were grown in YP
medium containing raffinose as a carbon source, or synthetic medium
containing sucrose. Galactose was added to a final concentration of
2%. The time of induction was generally 30 minutes but, in the case of
cells grown in sucrose, the induction period was 45 minutes. Transcrip-
tional repression was achieved by the addition of glucose to a final
concentration of 2% to the cell suspension. At the same time, cyclo-
heximide was added to a final concentration of 1 mg/ml to prevent
further translation of any mRNA.
Cell extracts and immunoblotting
Protein extracts from harvested yeast cells were made by TCA precipi-
tation after glass bead lysis [41]. Immunoblots were performed as
described [29]. Detection of Sic1p was with a polyclonal antibody (a
gift from L. Johnston), and detection of Myc-tagged Clb2 and Clb2∆1-
102p was with 9E10. After processing for immunoblotting, the mem-
brane was stained with amido black [32,42] to detect total proteins
and ensure equal sample loading and even transfer from the polyacryl-
amide gel to the membrane.
Supplementary material
Two tables listing the genotypes of the strains used in this study and
oligonucleotide primers used for site-directed mutagenesis are avail-
able at http://current-biology.com/supmat/supmatin.htm.
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